Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1788899 | 0.85 | LMNA (0.35) | TSHRLMNA | |
| SCHEMBL2677950 | 0.79 | ALDH1A1 (0.39) | TSHRLMNAALOX15 | |
| SCHEMBL11656302 | 0.79 | LMNA (0.46) | LMNA | |
| SCHEMBL806955 | 0.77 | TSHR (0.39) | TSHRLMNAALOX15 | |
| SCHEMBL14038948 | 0.77 | TSHR (0.39) | TSHRLMNAALOX15 | |
| SCHEMBL15472460 | 0.77 | TSHR (0.39) | TSHRLMNAALOX15 | |
| SCHEMBL15472453 | 0.77 | TSHR (0.39) | TSHRLMNAALOX15 | |
| SCHEMBL5544727 | 0.75 | TSHR (0.37) | TSHRLMNAALOX15 | |
| SCHEMBL882485 | 0.75 | TSHR (0.37) | TSHRLMNAALOX15 | |
| SCHEMBL27934777 | 0.75 | TSHR (0.37) | TSHRLMNAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7102019-B2 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-05 | — | — | US | disclosed |
| US-20040116522-A1 | Medicinal solutions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-06-17 | — | — | US | disclosed |
| US-20020034527-A1 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | STREICHER HARALD (DE) | 2002-03-21 | — | — | US | disclosed |
| US-4548932-A | ANGIOTENSIN INHIBITOR, HYPOTENSIVE AGENT | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-10-22 | — | — | US | disclosed |
| EP-0135349-A1 | Condensed seven-membered ring compounds and their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034527-A1 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | PROC, ALDH16A1, RCN1 | TSHR 3577/4885LMNA 1264/4885ALOX15 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.